LentiBOOST Now Used In More Than 35 Cell Therapy Clinical Trials!
SIRION Biotech's LentiBOOST Lentiviral Transduction Reagent is used in an ever-increasing number of...
SIRION Biotech's LentiBOOST Lentiviral Transduction Reagent is used in an ever-increasing number of...
Booth 61, Edinburgh International Conference Center, October 11 – 14, 2022
We have a great team...
EU-Japan Biotech Pharma Partnering Conference, October 11, Osaka
BioJapan (October 12—14, Yokohama)
Boston Convention and Exhibition CenterSeptember 27—30, Booth 631
In this GEN webinar, our distinguished guests, Dr. Arun Srivastava and Dr. David Schaffer will tell...
We are pleased to announce that we are expanding! Our new state-of-the-art laboratories will be...
SIRION Biotech is pleased to host the panel discussion on Safety Aspects of AAV and...
SIRION Biotech is now part of the Revvity portfolio!
SIRION Biotech licences its LentiBOOST® transduction technology to Cellectis
AAV Webinar
On Demand
CAR-TCR Summit
August 29 - September 1, Boston
Meet Benjamin Eberhardt, LentiBOOST Product Manager! Eberhardt@sirion-biotech.com
Japan Society of Cell and Gene Therapy
September 11 - September 13, Osaka
BIOJapan
October 11 - October 13, Yokohama